Physician

Spring K Golden, M.D.

According to 2025 Medicare claims, Spring Golden, M.D. (NPI: 1912292699) practices micrographic dermatologic surgery in the Urban Honolulu, HI market, with the plurality of this provider's patient population coming from Honolulu, HI. This provider's primary affiliated billing organization is GOLDEN DERMATOLOGY LLC (NPI: 1154866473; TIN: 812258553) and primary practice location at 96817-1605.

Golden's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 309 traditional Medicare patients, billed 1,999 HCPCS/CPT codes, and received $373,914 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 516 prescription claims across 245 beneficiaries totaling $135,529 in drug costs, led by Doxycycline Monohydrate (Doxycycline Monohydrate). Open Payments data shows 4 records totaling $89. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $4,549 to $135,529. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$199K$398K2016 Medicare payment: $8,340 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $136,944 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $333,370 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $398,273 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $316,428 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $227,524 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $290,524 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $334,122 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $373,914 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
201655125$8,340
2017171714$136,944
20183031,526$333,370
20193421,985$398,273
20202871,627$316,428
20212081,208$227,524
20222461,660$290,524
20232981,857$334,122
20243091,999$373,914

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$68K$136K2015 Drug cost: $4,549 (USD; Tot_Drug_Cst)2016 Drug cost: $2,491 (USD; Tot_Drug_Cst)2017 Drug cost: $4,872 (USD; Tot_Drug_Cst)2018 Drug cost: $9,572 (USD; Tot_Drug_Cst)2019 Drug cost: $18,248 (USD; Tot_Drug_Cst)2020 Drug cost: $16,441 (USD; Tot_Drug_Cst)2021 Drug cost: $12,779 (USD; Tot_Drug_Cst)2022 Drug cost: $35,130 (USD; Tot_Drug_Cst)2023 Drug cost: $71,887 (USD; Tot_Drug_Cst)2024 Drug cost: $135,529 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154988$4,549
2016101137$2,491
2017127200$4,872
2018220362$9,572
2019259385$18,248
2020145302$16,441
2021126264$12,779
2022187423$35,130
2023248544$71,887
2024245516$135,529

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks160197$476
17312Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks127230$363
13132Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm6978$214
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more128220$63
17000Destruction of precancer skin growth, 1 growth70128$42

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Doxycycline MonohydrateDoxycycline Monohydrate107811$1,859
TacrolimusTacrolimus12360$1,228
FluorouracilFluorouracil12360$978
Clobetasol PropionateClobetasol Propionate18517$693
MupirocinMupirocin881,862$653

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$89ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Spring K. Golden, M.D.?

Tedicare shows public-source Medicare data for Spring K. Golden, M.D. (NPI 1912292699), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Spring K. Golden, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Spring K. Golden, M.D.?

Spring K. Golden, M.D. is linked to GOLDEN DERMATOLOGY LLC (billing NPI 1154866473) in the available physician profile data.

Does Spring K. Golden, M.D. have Open Payments data?

Spring K. Golden, M.D. has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.